141 related articles for article (PubMed ID: 7692099)
1. The titanium intraprostatic stent: the United States experience.
Kaplan SA; Merrill DC; Mosely WG; Benson RC; Chiou RK; Fuselier HA; Parra RO
J Urol; 1993 Nov; 150(5 Pt 2):1624-9. PubMed ID: 7692099
[TBL] [Abstract][Full Text] [Related]
2. The UroLume stent in the management of benign prostatic hyperplasia.
Milroy E; Chapple CR
J Urol; 1993 Nov; 150(5 Pt 2):1630-5. PubMed ID: 7692100
[TBL] [Abstract][Full Text] [Related]
3. Thermo-expandable prostatic stents for bladder outlet obstruction in the frail and elderly population: An underutilized procedure?
Sethi K; Bozin M; Jabane T; McMullin R; Cook D; Forsyth R; Dodds L; Putra LJ
Investig Clin Urol; 2017 Nov; 58(6):447-452. PubMed ID: 29124245
[TBL] [Abstract][Full Text] [Related]
4. [Experience with the memotherm stent in high-risk urinary retention patients].
Maru N; Shitara T; Yamashita H; Minei S; Shimura S; Hamashima T; Baba S
Nihon Hinyokika Gakkai Zasshi; 2003 May; 94(4):481-6. PubMed ID: 12795162
[TBL] [Abstract][Full Text] [Related]
5. [Long-term results and indications of intraurethral stents in elderly patients with prostatic hypertrophy complaining of urinary retention].
Takeda M; Takahashi H; Tsutsui T; Go H; Hatano A; Sato S; Sasagawa T; Sakata Y; Hiraiwa M; Ando T
Hinyokika Kiyo; 1993 Nov; 39(11):1011-5. PubMed ID: 7505521
[TBL] [Abstract][Full Text] [Related]
6. Long-term experience utilizing a new balloon expandable prostatic endoprosthesis: the Titan stent. North American Titan Stent Study Group.
Kaplan SA; Chiou RK; Morton WJ; Katz PG
Urology; 1995 Feb; 45(2):234-40. PubMed ID: 7855972
[TBL] [Abstract][Full Text] [Related]
7. Prostatic spiral versus prostatic urolume wallstent for urinary retention due to benign prostatic hyperplasia. A long-term comparative study.
Guazzoni G; Montorsi F; Bergamaschi F; Consonni P; Bellinzoni P; Rigatti P
Eur Urol; 1993; 24(3):332-6. PubMed ID: 7505225
[TBL] [Abstract][Full Text] [Related]
8. Use of the ASI titanium stent in the management of bladder outflow obstruction due to benign prostatic hyperplasia.
Kirby RS; Heard SR; Miller P; Eardley I; Holmes S; Vale J; Bryan J; Liu S
J Urol; 1992 Oct; 148(4):1195-7. PubMed ID: 1383573
[TBL] [Abstract][Full Text] [Related]
9. Management of benign prostatic hyperplasia in high risk patients: long-term experience with the Memotherm stent.
Gesenberg A; Sintermann R
J Urol; 1998 Jul; 160(1):72-6. PubMed ID: 9628608
[TBL] [Abstract][Full Text] [Related]
10. The biodegradable self-reinforced poly-DL-lactic acid spiral stent compared with a suprapubic catheter in the treatment of post-operative urinary retention after visual laser ablation of the prostate.
Pétas A; Talja M; Tammela TL; Taari K; Välimaa T; Törmälä P
Br J Urol; 1997 Sep; 80(3):439-43. PubMed ID: 9313664
[TBL] [Abstract][Full Text] [Related]
11. Intraurethral catheter in high-risk patients with urinary retention: 3 years of experience.
Sassine AM; Schulman CC
Eur Urol; 1994; 25(2):131-4. PubMed ID: 7511105
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention.
Ghalayini IF; Al-Ghazo MA; Pickard RS
BJU Int; 2005 Jul; 96(1):93-7. PubMed ID: 15963128
[TBL] [Abstract][Full Text] [Related]
13. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia.
Carnevale FC; da Motta-Leal-Filho JM; Antunes AA; Baroni RH; Marcelino AS; Cerri LM; Yoshinaga EM; Cerri GG; Srougi M
J Vasc Interv Radiol; 2013 Apr; 24(4):535-42. PubMed ID: 23434084
[TBL] [Abstract][Full Text] [Related]
14. Feedback microwave thermotherapy with the ProstaLund Compact Device for obstructive benign prostatic hyperplasia: 12-month response rates and complications.
Alivizatos G; Ferakis N; Mitropoulos D; Skolarikos A; Livadas K; Kastriotis I
J Endourol; 2005; 19(1):72-8. PubMed ID: 15735388
[TBL] [Abstract][Full Text] [Related]
15. Experience with a new intraurethral stent for high-risk patients with benign prostatic hypertrophy.
Fuse H; Okumura A; Sakamoto M; Katayama T
Int Urol Nephrol; 1993; 25(4):369-74. PubMed ID: 7506240
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study.
Kotsar A; Isotalo T; Juuti H; Mikkonen J; Leppiniemi J; Hänninen V; Kellomäki M; Talja M; Tammela TL
BJU Int; 2009 Mar; 103(5):626-9. PubMed ID: 18990149
[TBL] [Abstract][Full Text] [Related]
17. [Initial experiences with the Memotherm Stent in treatment of benign prostatic hyperplasia].
Gottfried HW; Schimers HP; Gschwend J; Brändle E; Hautmann R
Urologe A; 1995 Mar; 34(2):110-8. PubMed ID: 7538708
[TBL] [Abstract][Full Text] [Related]
18. [Clinical efficacy of the Porges Urospiral, a reversible intraprostatic spiral stent, in patients with benign prostatic hypertrophy].
Uchida J; Kawamura H; Fujita I; Oguchi N; Matsuda T; Ashida M; Kikkawa A; Doi T; Amazutsumi K; Ohara T
Hinyokika Kiyo; 1995 Apr; 41(4):323-8. PubMed ID: 7540360
[TBL] [Abstract][Full Text] [Related]
19. A comparison of transrectal hyperthermia, transurethral thermotherapy, urolume wallstent, and prostatic spiral for benign prostatic hyperplasia patients at poor operative risk.
Montorsi F; Guazzoni G; Bergamaschi F; Consonni P; Galli L; Rigatti P
Prostate; 1994; 24(3):156-61. PubMed ID: 7509486
[TBL] [Abstract][Full Text] [Related]
20. Interstitial laser coagulation and biodegradable self-expandable, self-reinforced poly-L-lactic and poly-L-glycolic copolymer spiral stent in the treatment of benign prostatic enlargement.
Laaksovirta S; Isotalo T; Talja M; Välimaa T; Törmälä P; Tammela TL
J Endourol; 2002 Jun; 16(5):311-5. PubMed ID: 12184083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
